Beyond apoptosis, BPH involves dysregulation of the G1-S checkpoint, which is governed by cyclin D1/cyclin-dependent kinase (CDK) 4 and cyclin E/CDK2 and constrained by the CDK inhibitors p21 and p27 (Karimian et al., 2016). This evidence concerns the gene CDK2 and benign prostatic hyperplasia.